We used the METABRIC, Cell 2015, and PanCancer Atlas breast cancer datasets (extracted via cBioPortal) and KMplotter to assess PART1 expression in different breast cancer subtypes and its association with clinical data. Here, PART1 is linked to breast carcinoma.